Moloney Securities Asset Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $128K | Buy |
|
|||||
|
2025
Q2 | $120K | Buy |
|
|||||
|
2025
Q1 | $114K | Buy |
|
|||||
|
2024
Q4 | $134K | Buy |
|
|||||
|
2024
Q3 | $148K | Buy |
|
|||||
|
2024
Q2 | $181K | Buy |
|
|||||
|
2024
Q1 | $197K | Buy |
|
|||||
|
2023
Q4 | $251K | Buy |
|
|||||
|
2023
Q3 | $321K | Buy |
|
|||||
|
2023
Q2 | $187K | Buy |
|
|||||
|
2023
Q1 | $178K | Sell |
|
|||||
|
2022
Q4 | $224K | Buy |
|
|||||
|
2022
Q3 | $204K | Buy |
|
|||||
|
2022
Q2 | $179K | Buy |
|
|||||
|
2022
Q1 | $194K | Buy |
|
|||||
|
2021
Q4 | $162K | Buy |
|
|||||
|
2021
Q3 | $215K | Buy |
|
|||||
|
2021
Q2 | $235K | Buy |
|
|||||
|
2021
Q1 | $207K | Buy |
|
|||||
|
2020
Q4 | $159K | Buy |
|
|||||
|
2020
Q3 | $38K | Buy |
|
|||||
|
2020
Q2 | $11K | Buy |
|
|||||
|
2020
Q1 | $5K | Buy |
|